Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Neuropathology and Applied Neurobiology
|
January 29, 2008
Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7)
F Hoche, K Seidel, E R Brunt, et al.
Nature Medicine
|
December 1, 2001
Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment
J Priller, A Flügel, T Wehner, et al.
Neuropathology and Applied Neurobiology
|
November 1, 2007
Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments
U Rüb, E R Brunt, K Seidel, et al.
Nature Communications
|
August 4, 2018
Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy
R Fledrich, T Abdelaal, L Rasch, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Neuropathology and Applied Neurobiology
|
January 29, 2008
Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7)
F Hoche, K Seidel, E R Brunt, et al.
Nature Medicine
|
December 1, 2001
Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment
J Priller, A Flügel, T Wehner, et al.
Neuropathology and Applied Neurobiology
|
November 1, 2007
Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments
U Rüb, E R Brunt, K Seidel, et al.
Nature Communications
|
August 4, 2018
Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy
R Fledrich, T Abdelaal, L Rasch, et al.
Page
of 4